Clinical Trials Browser

Phase 2 × Lung Neoplasms × soblidotin × Clear all

NCT00061854 2012-05-16

Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms